Renovaro Inc. (RENB)
NASDAQ: RENB · Real-Time Price · USD
0.825
-0.022 (-2.59%)
At close: Feb 21, 2025, 4:00 PM
0.800
-0.024 (-2.97%)
After-hours: Feb 21, 2025, 6:37 PM EST
Renovaro Market Cap
Renovaro has a market cap or net worth of $130.93 million as of February 21, 2025. Its market cap has decreased by -54.56% in one year.
Market Cap
130.93M
Enterprise Value
137.80M
1-Year Change
-54.56%
Ranking
Category
Stock Price
$0.82
Market Cap Chart
Since December 11, 2018, Renovaro's market cap has decreased from $252.00M to $130.93M, a decrease of -48.05%. That is a compound annual growth rate of -10.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 130.90M | -1.36% |
| Dec 31, 2024 | 132.70M | -37.23% |
| Dec 29, 2023 | 211.40M | 287.89% |
| Dec 30, 2022 | 54.50M | -85.68% |
| Dec 31, 2021 | 380.70M | 176.67% |
| Dec 31, 2020 | 137.60M | -40.77% |
| Dec 31, 2019 | 232.30M | -8.25% |
| Dec 31, 2018 | 253.20M | 0.48% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |